CSC | cancer stem cells |
DHFR | dihydrofolate reductase |
GB | glioblastoma |
EGFR | epidermal growth factor receptor |
eIF4E | eukaryotic translation initiation factor 4E |
HCC | hepatocellular carcinoma |
MMP-9 | matrix metalloproteinase-9 |
MOA | mode of action |
MR | mineralocorticoid receptor |
MTX | methotrexate |
NSCLC | non-small cell carcinoma |